Article Information
History
- November 13, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Marco Toffoli*,1,
- Xiao Chen*,2,
- Fritz J Sedlazeck3,
- Chiao-Yin Lee1,
- Stephen Mullin1,4,
- Abigail Higgins1,
- Sofia Koletsi1,
- Monica Emili Garcia-Segura1,
- Esther Sammler5,6,
- Sonja W. Scholz7,8,
- Anthony HV Schapira1,
- Michael A. Eberle**,2 and
- Christos Proukakis**,1
- 1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, WC1N 3BG, United Kingdom
- 2Illumina Inc., San Diego, CA, USA
- 3Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
- 4Institute of Translational and Stratified Medicine, University of Plymouth School of Medicine, Plymouth, United Kingdom
- 5MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee
- 6Molecular and Clinical Medicine, School of Medicine, University of Dundee
- 7Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892, USA
- 8Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD 21287, USA
- ↵**corresponding authors, equal contributions correspondence email(s) c.proukakis{at}ucl.ac.uk, meberle{at}illumina.com
↵* equal contributions
Posted November 13, 2021.
Comprehensive analysis of GBA using a novel algorithm for Illumina whole-genome sequence data or targeted Nanopore sequencing
